查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1513934

肾结石管理设备的全球市场

Kidney Stone Management Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球肾结石管理设备市场预计将达到 23 亿美元

2023 年全球肾结石管理设备市场估计为 17 亿美元，预计到 2030 年将达到 23 亿美元，2023-2030 年分析期间复合年增长率为 4.8%。输尿管镜检查是本报告分析的细分市场之一，预计复合年增长率为 5.4%，到分析期结束时将达到 13 亿美元。分析期间碎石机领域的复合年增长率预计为 4.3%。

美国市场预计将达到4.466亿美元，中国预计复合年增长率为8.1%。

预计 2023 年美国肾结石管理设备市场规模将达 4.466 亿美元。中国作为全球第二大经济体，预计2030年市场规模将达4.945亿美元，2023年至2030年复合年增长率为8.1%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 2.4% 和 3.9%。在欧洲，德国的复合年增长率预计为 3.1%。

肾结石管理设备 - 主要趋势和驱动因素

肾结石管理设备是专门用于诊断、治疗和管理肾结石的医疗设备，肾结石是一种影响全球数百万人的常见泌尿系统疾病。这些设备包括多种技术和设备，包括体外震波碎石机 (ESWL)、输尿管镜、肾臟镜、雷射碎石机和支架。 ESWL 装置使用衝击波将肾结石分解成更小的碎片，让它们自行排出。输尿管镜和肾镜是内视镜器械，可以分别直接观察和清除泌尿道和肾臟的结石。雷射碎石机利用雷射能量碎石，是一种高精度、微创的治疗方法。支架用于确保尿液流动、预防併发症并帮助结石去除或碎裂后的恢復。这些设备对于根据肾结石的大小、位置和成分提供有效的治疗方法至关重要。

肾结石管理设备市场正在受到多种趋势的影响，反映了医疗技术的进步和患者照护方法的变化。一个重要的趋势是，由于患者需要更快的恢復时间和更低的併发症发生率，因此越来越多地采用微创手术。这导致输尿管软镜和雷射碎石机的使用越来越多，它们可以准确有效地去除结石，同时将不适感降到最低。技术进步也增强了 ESWL 设备的功能，提高了其准确性和有效性。另一个值得注意的趋势是将超音波和透视等成像技术整合到结石管理设备中，以帮助可视化和定位结石。此外，饮食和肥胖等生活方式因素导致肾结石盛行率不断上升，这推动了对先进管理解决方案的需求。此外，支架设计的创新正在减少与支架相关的不适和併发症，并改善患者的治疗结果。

肾结石管理设备市场的成长受到多种因素的推动。技术的进步提高了取石手术的准确性、效率和安全性，使更广泛的患者更容易获得和有效地进行取石手术。由于饮食改变、脱水和久坐的生活方式，肾结石盛行率不断上升，这加大了对有效管理解决方案的需求。此外，人们对肾结石认识的提高和先进治疗方案的可用性正在导致更多患者寻求及时的医疗干预。微创手术的趋势也是主要动力。这是因为这些手术可以减轻疼痛、缩短住院时间并加快復原时间。医疗保健提供者越来越多地采用这些先进设备来改善患者护理和治疗结果。此外，可携式且易于使用的设备的发展使得门诊病人和欠发达地区更容易进行肾结石治疗。政府对肾结石治疗的支持和优惠报销政策进一步推动了市场成长。总体而言，这些因素正在推动肾结石治疗设备市场的强劲成长，满足对有效和高效治疗方案不断增长的需求。

受访企业范例（共48家）

  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast Group
  • Cook Medical
  • DirexGroup
  • Dornier MedTech
  • EMS Electro Medical Systems SA
  • EDAP TMS SA
  • Lumenis Ltd.
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers
  • Storz Medical AG

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP-6467

Global Kidney Stone Management Devices Market to Reach US$2.3 Billion by 2030

The global market for Kidney Stone Management Devices estimated at US$1.7 Billion in the year 2023, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Ureteroscopy, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Lithotripsy segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$446.6 Million While China is Forecast to Grow at 8.1% CAGR

The Kidney Stone Management Devices market in the U.S. is estimated at US$446.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$494.5 Million by the year 2030 trailing a CAGR of 8.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Kidney Stone Management Devices - Key Trends and Drivers

Kidney stone management devices are specialized medical tools designed to diagnose, treat, and manage kidney stones, a common urological condition affecting millions worldwide. These devices encompass a range of technologies and instruments, including extracorporeal shock wave lithotripsy (ESWL) machines, ureteroscopes, nephroscopes, laser lithotripters, and stents. ESWL machines use shock waves to break down kidney stones into smaller fragments that can be passed naturally. Ureteroscopes and nephroscopes are endoscopic devices that allow for the direct visualization and removal of stones within the urinary tract and kidney, respectively. Laser lithotripters utilize laser energy to fragment stones, offering a minimally invasive solution with high precision. Stents are used to ensure the free flow of urine after the removal or fragmentation of stones, preventing complications and aiding recovery. These devices are critical in providing effective treatment options tailored to the size, location, and composition of kidney stones.

Several trends are shaping the kidney stone management devices market, reflecting advancements in medical technology and changes in patient care approaches. One significant trend is the increasing adoption of minimally invasive procedures, driven by patient demand for reduced recovery times and lower complication rates. This has led to the growing use of flexible ureteroscopes and laser lithotripters, which allow for precise and efficient stone removal with minimal discomfort. Technological advancements are also enhancing the capabilities of ESWL machines, improving their accuracy and effectiveness. The integration of imaging technologies, such as ultrasound and fluoroscopy, with stone management devices is another notable trend, enabling better visualization and targeting of stones. Additionally, the rise in the prevalence of kidney stones, partly due to lifestyle factors such as diet and obesity, is driving the demand for advanced management solutions. Furthermore, innovations in stent design are improving patient outcomes by reducing stent-related discomfort and complications.

The growth in the kidney stone management devices market is driven by several factors. Technological advancements are enhancing the precision, efficiency, and safety of stone removal procedures, making them more accessible and effective for a broader range of patients. The increasing prevalence of kidney stones, fueled by dietary changes, dehydration, and sedentary lifestyles, is expanding the need for effective management solutions. Additionally, the growing awareness of kidney stone disease and the availability of advanced treatment options are encouraging more patients to seek timely medical intervention. The trend towards minimally invasive surgeries is also a significant driver, as these procedures offer reduced pain, shorter hospital stays, and quicker recovery times. Healthcare providers are increasingly adopting these advanced devices to improve patient care and outcomes. Moreover, the development of portable and user-friendly devices is making kidney stone management more accessible in outpatient settings and less developed regions. Government support and favorable reimbursement policies for kidney stone treatments are further propelling market growth. Overall, these factors are fostering robust growth in the kidney stone management devices market, meeting the rising demand for effective and efficient treatment options.

Select Competitors (Total 48 Featured) -

  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast Group
  • Cook Medical
  • DirexGroup
  • Dornier MedTech
  • E.M.S. Electro Medical Systems S.A.
  • EDAP TMS SA
  • Lumenis Ltd.
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers
  • Storz Medical AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Kidney Stone Management Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Kidney Stones Drives Demand for Advanced Management Solutions
    • Increasing Adoption of Minimally Invasive Procedures Propels Growth in Kidney Stone Management Devices
    • Technological Advancements in ESWL Machines Strengthen Business Case for Non-Invasive Treatments
    • Integration of Imaging Technologies Expands Addressable Market Opportunity for Precision Stone Removal
    • Innovations in Stent Design Here's How They Improve Patient Outcomes and Reduce Complications
    • Lifestyle Factors Such as Diet and Obesity Spur Growth in Kidney Stone Management Market
    • Growing Awareness of Kidney Stone Disease Generates Demand for Timely Medical Interventions
    • Development of Flexible Ureteroscopes Drives Adoption of Efficient Stone Removal Techniques
    • Increasing Use of Laser Lithotripters: Here's the Story for Precision and Minimal Discomfort in Stone Management
    • Trend towards Outpatient Procedures Expands Market Reach for Portable and User-Friendly Devices
    • Advances in Endoscopic Technologies Spur Growth in Efficient and Effective Stone Removal Solutions
    • Consumer Demand for Reduced Recovery Times and Lower Complication Rates Drives Minimally Invasive Techniques
    • Expansion of Urology Clinics and Specialized Healthcare Centers Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Kidney Stone Management Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Kidney Stone Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ureteroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Ureteroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Ureteroscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Lithotripsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Lithotripsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Lithotripsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Percutaneous Nephrolithonomy (PCNL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Percutaneous Nephrolithonomy (PCNL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Percutaneous Nephrolithonomy (PCNL) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Kidney Stone Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Kidney Stone Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • INDIA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Kidney Stone Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Kidney Stone Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • AFRICA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030

IV. COMPETITION